Cytokinetics, Incorporated
Cytokinetics is a clinical-stage biopharmaceutical company developing cardiac and skeletal muscle activators with minimal direct government dependence but significant FDA regulatory exposure.
BusinessWhat CYTK does
Cytokinetics discovers and develops small-molecule therapeutics targeting cardiac and skeletal muscle function, primarily for heart failure and neuromuscular diseases. The company is pre-commercial or early-commercial, with revenue dependent on clinical trial progression, regulatory approvals, and eventual commercialization partnerships or licensing deals.
12 months past · 3 months futureCYTK activity timeline
Lifetime Government AwardsCYTK federal contracts
CYTK doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding CYTK
Politicians Trading CYTKMembers of Congress with recent CYTK positions
Congressional TradesWho in Congress is trading CYTK
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting CYTKLive legislation impacting this stock
Political ProfileWhere CYTK sits in Washington
Clinical-stage biotech stocks are driven primarily by clinical trial results, FDA decisions, and capital markets rather than legislative/regulatory news. Politician trades appear incidental rather than signal-driven.
Regulatory ExposureThreats & opportunities
Regulatory threats
- FDA clinical trial delays
- Medicare pricing pressure on future commercialized products
- patent litigation
Regulatory opportunities
- Breakthrough Therapy designation
- Accelerated Approval pathway
- NIH grant funding
Live signals + predictions for CYTK — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades CYTK
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord